| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.00066 | 1 |
| mRNA | doxorubicin:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.00056 | 1 |
| mRNA | OSI-027 | CTRPv2 | pan-cancer | AAC | -0.00055 | 1 |
| mRNA | MS-275 | CTRPv2 | pan-cancer | AAC | 0.00034 | 1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.0016 | 1 |
| mRNA | thalidomide | CTRPv2 | pan-cancer | AAC | -0.0004 | 1 |